Huabing Chen
Impact in
- Pharmaceutical Science top 0.1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 56
- Biomaterials 31
- Nanoparticle-Based Drug Delivery 31
- Co-authors
- Xiangliang Yang (31 shared papers)Hengte Ke (33 shared papers)Huibi Xu (16 shared papers)Tao Yang (28 shared papers)Yibin Deng (25 shared papers)Aijun Zhu (13 shared papers)Hong Yang (14 shared papers)Zhengqing Guo (16 shared papers)
- Journals
- Advanced Materials (15 papers)ACS Nano (10 papers)Journal of Controlled Release (8 papers)Biomaterials (6 papers)Advanced Functional Materials (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Huabing Chen
86 papers receiving 9.6k citations
Huabing Chen's Hit Papers
Peers
Comparison fields: 5 of 144
- Pharmaceutical Science 1.7k
- Biomaterials 2.8k
- Biomedical Engineering 5.4k
- Materials Chemistry 3.3k
- Molecular Medicine 249
Countries citing papers authored by Huabing Chen
This map shows the geographic impact of Huabing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huabing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huabing Chen more than expected).
Fields of papers citing papers by Huabing Chen
This network shows the impact of papers produced by Huabing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huabing Chen. The network helps show where Huabing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Huabing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent progress in drug delivery Hit paper breakdown → | 2019 | 626 |
| 2 | Nanonization strategies for poorly water-soluble drugs Hit paper breakdown → | 2010 | 519 |
| 3 | In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics Hit paper breakdown → | 2016 | 396 |
| 4 | 2017 | 373 | |
| 5 | 2006 | 323 | |
| 6 | 2015 | 290 | |
| 7 | 2013 | 273 | |
| 8 | 2004 | 263 | |
| 9 | 2006 | 253 | |
| 10 | 2005 | 249 | |
| 11 | 2019 | 232 | |
| 12 | 2017 | 219 | |
| 13 | 2016 | 202 | |
| 14 | 2014 | 201 | |
| 15 | 2017 | 192 | |
| 16 | 2017 | 187 | |
| 17 | 2016 | 184 | |
| 18 | 2018 | 183 | |
| 19 | 2016 | 181 | |
| 20 | 2016 | 180 |
About Huabing Chen
Huabing Chen is a scholar working on Biomedical Engineering, Biomaterials, Materials Chemistry, Molecular Biology and Pharmaceutical Science, having authored 89 papers that have together received 9.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (56 papers), Nanoparticle-Based Drug Delivery (31 papers), Luminescence and Fluorescent Materials (12 papers), Photodynamic Therapy Research Studies (9 papers), Advancements in Transdermal Drug Delivery (9 papers), Extracellular vesicles in disease (9 papers), Gold and Silver Nanoparticles Synthesis and Applications (8 papers) and Nanocluster Synthesis and Applications (8 papers). The work is most often cited by research in Pharmaceutical Science (1.7k citations), Biomaterials (2.8k citations), Biomedical Engineering (5.4k citations), Materials Chemistry (3.3k citations) and Molecular Medicine (249 citations). Huabing Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiangliang Yang, Hengte Ke, Huibi Xu, Tao Yang, Yibin Deng, Aijun Zhu, Hong Yang, Zhengqing Guo, Jinming Gao and Xueling Chang. Their work appears in journals such as Advanced Materials, ACS Nano, Journal of Controlled Release, Biomaterials and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.